Skip to Content

V16 9116 (Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease)

Generic Name: pancrelipase

Pill with imprint V16 9116 is Tan, Elliptical / Oval and has been identified as Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease. It is supplied by Allergan, Inc..

Viokace is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for V16 9116

Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease V16 9116
Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease V16 9116
Viokace 78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease V16 9116

Viokace

Generic Name:
pancrelipase
Imprint:
V16 9116
Strength:
78,300 USP units amylase; 20,880 USP units lipase; 78,300 USP units protease
Color:
Tan
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Allergan, Inc.
National Drug Code (NDC):
58914-0117

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide